THE MCC Today and the future Mandisa Hela. Let us recap on OBLIGATIONS Public safety & protection through ensuring efficacy, safety & quality of medicines.

Slides:



Advertisements
Similar presentations
Employability and Employer Engagement
Advertisements

Armand Racine Consultant Chemicals Branch
Local Public Health System Assessment
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
National Public Health Performance Standards Program Orientation to the Essential Public Health Services.
From e-Government to e-Governance: The OECD Experience Elizabeth Muller E-Government Project OECD SitExpo February 1004, Casablanca - Morocco.
1 Trade facilitation: Benefits and Capacity Building for Customs UNECE International Forum on Trade Facilitation, May 2003 Kunio Mikuriya Deputy.
WMO WIGOS in support of DRR 2013 Coordination Meeting of DRR FP October 2013, Geneva Dr S. Barrell, Chair, ICG-WIGOS Dr I. Zahumensky, WIGOS-PO.
COMPETITION POLICY AND ECONOMIC DEVELOPMENT PRESENTATION AT CUTS-ARC CAPACITY BUILDING WORKSHOP, LUSAKA 7 TH MARCH, 2011 BY SAJEEV NAIR, COMPETITION POLICY.
1 SG C Commission Communication on EU Regulatory Fitness COM (2012) 746 Working Group on Better Regulation Meeting of 4 th March, 2013 Michael Gremminger.
TECHNICAL VOCATIONAL EDUCATIONAL AND TRAINING COLLEGES AN INTRODUCTION TO THE IMPEMENTATION OF A COMPLIANT RISK MANAGEMENT PROCESS July 2014.
Lucy Namu on 2 nd September 2014 A presentation made during the New Zealand and South Africa Trilateral Workshop by Food Safety Systems for Export – A.
Options for Regulation and the Impact of Regulation on the Marketplace 29 November 2005 Alan Kent
11 th International Symposium Loss Prevention and Process Safety Promotion in the Process Industries 1 OECD Workshop on Sharing Experience in the Training.
International Regulatory Capacity Building Global Curriculum Project.
Regulatory Body MODIFIED Day 8 – Lecture 3.
1 Webinar on: Establishing a Fully Integrated National Food Safety System with Strengthened Inspection, Laboratory and Response Capacity Sponsored by Partnership.
Applying the Federal Cabinet Directive on Streamlining Regulation Regulatory Craft in Nova Scotia Conference 2007 Halifax, Nova Scotia November 20, 2007.
Executive summary prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY RISK MANAGEMENT.
A Common Immigration Policy for Europe Principles, actions and tools June 2008.
“Critical Path” for Food and Nutrition Science Board November 5, 2004 Alan M. Rulis.
Key Elements of Legislation For Disaster Risk Reduction Second Meeting of Asian Advisory Group of Parliamentarians for DRR 5-7 February, 2014, Vientiane,
Update and future directions for prequalification of medicines WHO HQ, Geneva, 4 February 2008 Dr Lembit Rägo Coordinator Quality Assurance and Safety:
DG Enterprise and Industry Philippe JEAN Sustainable Mobility & Automotive Industry Unit WP.29 Enforcement Working Group meeting 27 June update.
IAEA International Atomic Energy Agency Senior Regulators Meeting Technical Cooperation Programme Supporting Radiation Safety Infrastructure in Member.
1 Hsin Chu, August 2012 Regulatory Impact Assessment Charles-Henri Montin, Senior Regulatory Expert, Ministry of economy and finance, Paris
Terezia Sinkova EFSA The new EU Food Safety Agency.
Assuring Public Safety and Assessing Risk Across Sectors The Essence of Regulatory Focus John Paterson University of Aberdeen.
SAHPRA proposals Nov 2009 A GLIMPSE OF WHAT SAHPRA IS INTENDED TO BECOME KEY PROPOSALS FOR SAHPRA NOVEMBER 2009 DR NICHOLAS CRISP.
8 TH -11 TH NOVEMBER, 2010 UN Complex, Nairobi, Kenya MEETING OUTCOMES David Smith, Manager PEI Africa.
Regulation and the Governance Agenda in the 21 st Century Josef Konvitz, Public Governance Directorate.
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
International ILO Conference - November 2009 Maurice Dhooge Global Health & Safety Department.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Legislation.
The Canada Border Services Agency and Coordinated Border Management Regional Conference of Customs Directors General, April 22-25, 2012.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Regulatory Authority.
Biologics and Genetic Therapies Directorate Health Products and Food Branch HEALTH CANADA Helping Canadians maintain and improve their health. Agnes Klein.
The Role of Peer Review in a Multilateral Framework on Competition Policy Andrea Bruce Investment Trade Policy UNCTAD Regional Seminar for Latin America.
IPASA presentation to Portfolio Committee on Health 31 October 2014 Abeda Williams.
ITU CoE/ARB 11 th Annual Meeting of the Arab Network for Human Resources 16 – 18 December 2003; Khartoum - Sudan 1 The content is based on New OECD Guidelines.
United States-Canada Regulatory Cooperation Council TBWG Fall Plenary November,
IAEA International Atomic Energy Agency RER2006 RTC Establishing a Nuclear Safety Infrastructure for a National Nuclear Power Programme Wrap up, Where.
1 Vision: To be an agency producing outputs that contribute to optimal efficiency of the Indonesian Universal Health Coverage (UHC) Mission: To ensure.
National Public Health Performance Standards Local Assessment Instrument Essential Service:6 Enforce Laws and Regulations that Protect Health and Ensure.
1 Planning and Programming for Effective Use of External Audit Resources Victor Rezendes Managing Director Strategic Issues U.S. General Accounting Office.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
PHDSC Privacy, Security, and Data Sharing Committee Letter to Governors.
Future needs for capacity building and recommendations to the OIE Dr Sarah Kahn Consultant to the OIE
SOLGM Wanaka Retreat Health and Safety at Work Act 2015 Ready? 4 February 2016 Samantha Turner Partner DDI: Mob:
Overview of Good Regulatory Practice Kent Shigetomi Office of the U.S. Trade Representative.
The UI Federal/State Partnership At Work REENGINEERING UI BENEFIT ACCOUNTABILITY PROCESSES.
HEALTH AND CARE STANDARDS APRIL Background Ministerial commitment 2013 – Safe Care Compassionate Care Review “Doing Well Doing Better” Standards.
Girfec Origins What is Girfec? Getting it right for every child is the national approach to improving outcomes for all children by placing the child.
1 From Regulatory Intelligence to Compliance Debbie Henderson Head, Global Regulatory Policy EU Ring May 13, 2014.
Crisis management related research at
National Department of Health
Medicines Control Council (MCC) &
The New Legislative Framework Miniseminar New Legal Framework Reykjavík, 10 December 2008 Doris Gradenegger Unit C1: Regulatory Approach for the Free.
CDRH 2010 Strategic Priorities
Vision, Mission, and Goals
Institutional Framework, Resources and Management
Medicines Control Council (MCC) &
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Outcomes of Working Group 1
EUnetHTA Assembly May 2018.
Overview of Good Regulatory Practice
An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
Collaborative regulation in the digital economy
Presentation transcript:

THE MCC Today and the future Mandisa Hela

Let us recap on OBLIGATIONS Public safety & protection through ensuring efficacy, safety & quality of medicines throughout their lifecycle Risk assessment – minimization of harm and maximization of benefit Timely access to medicines & timely action on safety & quality Transparency & accountability Responsiveness Capacity to regulate 2

How is the MCC doing ? Quality of reviews – well Members of PICS Supply chain integrity - reasonable Timeliness – poor Transparency – limited Responsiveness – needs improvement Capacity – suboptimal

Where did we go wrong ? Current structure conceived more than 40 years ago Over - reliance on external experts Internal technical expertise limited – Government department Government implemented pro-access policies without doing an impact assessment, analysing and adapting affected units

Gaps Do not regulate complementary and alternative medicines Do not regulate African traditional medicines Do not regulate medical devices and in vitro diagnostics Do not regulate cosmetics Do not adequately regulate blood products and antivenins Do not adequately regulate adequately starting materials - amending legislation

HOW ARE WE FILLING THE GAPS Establishment of SAHPRA as public entity  Regulation of orthodox medicines  Regulation of complementary and alternative medicines  Regulation of African traditional medicines  Regulation of medical devices and in vitro diagnostics  Regulation of foodstuffs and cosmetics

How are we filling the gaps ? cont. Increasing internal capacity  Numbers  Skills base  Attitude  Improve peer review system – frequency of meetings  Specialised areas -retainer system  Reorganise the appeal process Cooperation with recognised regulatory authorities on cutting edge issues

Current challenges New technologies which respond to conditions exclusively or overwhelmingly prevalent in our country e.g. MDR and XDR TB New type of applicant e.g. Product Development Partnerships Balancing early access to new drugs with the need for comprehensive data Managing newer technologies e.g. biosimilars Managing borderline devices or medicines Maintaining access for older molecules 8

Emerging challenges Regulation of advanced therapy medicinal products  Gene therapy medicinal products, Tissue engineered products, biologicals containing GMOs  Combined products with devices used as excipients or carriers  Emerging / evolving areas e.g. Advanced therapies with accompanying diagnostics 9

What is happening globally? Work sharing among regulators Co-evaluation Abridged methods that avoid duplication of effort In relation to supply chain integrity: electronic symbology initiatives to ensure interoperability of tracking systems across the supply chain Linkage between regulators and Health technology assessment Involvement of the public in regulation 10

What is the way forward ? Co- operation with other regulators is imperative from an efficiency, capacity and responsiveness point of view How? What is in the tool box? What frameworks do we need? Are currently available tools sharp enough? Are they robust enough? What can we adapt to attain a perfect fit to our needs? 11

Food choices

Stepping Stones Shared vision Consistency, transparency and responsiveness Communication, education & training Common standards Enabling Legal instruments Coordination & cooperation Trust & mutual respect A pinch of optimism, an ounce of patience and a healthy dose of perseverance 15

A glimpse into the future Is all this pointing to a global regulatory body? If so what checks and balances are necessary to ensure national regulatory authorities are responsible for the benefit /risk assurance for their citizens? What frameworks are necessary to ensure vigilance, responsiveness and appropriateness to different circumstances are maintained? How will growth be ensured? 16

Conclusion Prioritise the public good No one can do it alone Familiarisation with global initiatives is a MUST Good regulatory principles still apply – It is about accurate data, data elements, trust, responsiveness, sharing, consistency & transparency Improve on communication and legitimacy 17

Conclusion cont. Trust is rebuilt by focusing not on what the other person did or did not do but on critiquing one's own behavior, improving one's trustworthiness and focusing attention not on words and promises but on actions, attitudes, and ways of being. Kenneth Cloke and Joan Goldsmith The Art of waking people up 18